About this Event
The UPNAT Symposium, taking place on 23 November 2026 at Sidney Sussex College, Cambridge, will bring together leading experts from academia, clinical research, industry, regulatory organisations and the patient community to address the practical challenges of translating nucleic acid therapies into treatments for rare diseases.
With contributions spanning therapeutic target assessment and prioritisation, preclinical safety and toxicology, regulatory requirements, drug development, genomic infrastructure and patient identification, the symposium will explore what is needed to build an effective UK pathway from genetic diagnosis to treatment. Particular focus will be placed on connecting existing expertise and infrastructure, overcoming barriers to therapeutic development, and establishing the frameworks and collaborations needed to deliver safe, effective and accessible therapies to patients.
Through expert presentations and panel discussions, the UPNAT Symposium aims to identify opportunities for greater coordination across the UK landscape and help shape the next steps towards accelerating the development and implementation of nucleic acid therapies for people living with rare diseases.
Full details are available on the UPNAT website, here: https://www.upnat.org.uk/2026-symposium
Event venue & nearby stays
Sidney Sussex College, Sidney Street, Cambridge, United Kingdom